Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
3,754,318
Value
$1.13B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,754,318$1.13B0.1%−320,802−7.9%ReducedHolders
Q1 20264,075,120$1.35B0.1%−1,058,863−20.6%ReducedHolders
Q4 20255,133,983$2.04B0.2%+3,652,141+246.5%AddedHolders
Q3 20251,481,842$675.7M0.1%+140,148+10.4%AddedHolders
Q2 20251,341,694$437.5M0.1%+427,902+46.8%AddedHolders
Q1 2025913,792$246.7M<0.1%+355,302+63.6%AddedHolders
Q4 2024558,490$131.4M<0.1%−137,378−19.7%ReducedHolders
Q3 2024695,868$191.4M<0.1%+303,027+77.1%AddedHolders
Q2 2024392,841$95.5M<0.1%+214,528+120.3%AddedHolders
Q1 2024178,313$26.6M<0.1%+1,453+0.8%AddedHolders
Q4 2023176,860$33.9M<0.1%−39,709−18.3%ReducedHolders
Q3 2023216,569$38.4M<0.1%−173,558−44.5%ReducedHolders
Q2 2023390,127$74.1M<0.1%+22,752+6.2%AddedHolders
Q1 2023367,375$73.6M<0.1%−302,474−45.2%ReducedHolders
Q4 2022669,849$159.2M<0.1%−67,981−9.2%ReducedHolders
Q3 2022737,830$147.7M<0.1%+568,999+337.0%AddedHolders
Q2 2022168,831$24.6M<0.1%−799,924−82.6%ReducedHolders
Q1 2022968,755$158.2M<0.1%+78,665+8.8%AddedHolders
Q4 2021890,090$150.9M<0.1%−164,082−15.6%ReducedHolders
Q3 20211,054,172$199.0M0.1%+52,271+5.2%AddedHolders
Q2 20211,001,901$169.8M<0.1%−214,202−17.6%ReducedHolders
Q1 20211,216,103$171.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.